SCHEMBL10320719

SCHEMBL10320719

COCCOCCOc1cc2cc(C(=O)OC)c(=O)[nH]c2cc1OC

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DYRK1A Q13627 2/20 0.52
DYRK1B Q9Y463 1/20 0.52
ALDH1A1 P00352 9/20 0.42
KDM4E B2RXH2 9/20 0.42
HPGD P15428 4/20 0.42
HSD17B10 Q99714 4/20 0.42
GAA P10253 4/20 0.42
TSHR P16473 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
SRD5A1 P18405 1/20 0.40
SRD5A2 P31213 1/20 0.40
USP2 O75604 1/20 0.40
CASP1 P29466 1/20 0.40
CASP7 P55210 1/20 0.40
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
GRIN2D O15399 1/20 0.39
GRIN3B O60391 1/20 0.39
GRIN1 Q05586 1/20 0.39
GRIN2A Q12879 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10318671 0.96 DYRK1A (0.54) DYRK1ADYRK1BALDH1A1KDM4EHPGD
SCHEMBL10319867 0.96 DYRK1A (0.54) DYRK1ADYRK1BALDH1A1KDM4EHPGD
SCHEMBL10320590 0.93 DYRK1A (0.49) DYRK1ADYRK1BALDH1A1KDM4EHPGD
SCHEMBL10320933 0.90 ALDH1A1 (0.49) DYRK1ADYRK1BALDH1A1KDM4EHPGD
SCHEMBL11952534 0.90 DYRK1A (0.53) DYRK1ADYRK1BALDH1A1KDM4EHPGD
SCHEMBL10318325 0.86 ALDH1A1 (0.52) DYRK1ADYRK1BALDH1A1KDM4EHPGD
SCHEMBL10319010 0.86 ALDH1A1 (0.52) DYRK1ADYRK1BALDH1A1KDM4EHPGD
SCHEMBL10319865 0.85 DYRK1A (0.61) DYRK1ADYRK1BALDH1A1KDM4EHPGD
SCHEMBL4416433 0.85 DYRK1A (0.50) DYRK1ADYRK1B
SCHEMBL10321066 0.82 KDM4E (0.52) DYRK1ADYRK1BALDH1A1KDM4EHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012098070-A1 QUINOLINE DYRK1 INHIBITORS F. HOFFMANN-LA ROCHE AG (CH) 2012-07-26 WO disclosed
US-20120184548-A1 CARBOXYLIC ACID ARYL AMIDES DOMINIQUE ROMYR (US) 2012-07-19 US disclosed
US-20120184548-A1 CARBOXYLIC ACID ARYL AMIDES DOMINIQUE ROMYR (US) 2012-07-19 US disclosed
US-20120184548-A1 CARBOXYLIC ACID ARYL AMIDES DOMINIQUE ROMYR (US) 2012-07-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120184548-A1 CARBOXYLIC ACID ARYL AMIDES GOT1, PPARG, PPARA DYRK1A 2480/4885DYRK1B 3023/4885ALDH1A1 62/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.